Scientific Advisory Board
Dr. H. William Strauss
Dr. Strauss currently serves as an Attending Physician Emeritus of the Molecular Imaging and Therapy Nuclear Medicine Service at Memorial Sloan Kettering Cancer Center & Memorial Hospital in New York City. He joined the Memorial Sloan Kettering/Cornell faculty and staff in 2001, following 30 years of faculty, clinical and research appointments in radiology at the medical schools and teaching hospitals of Johns Hopkins, Harvard, Stanford and Cornell University medical centers. For two years in the early 1990s, he also served as Vice President-Diagnostics Drug Discovery for Bristol-Myers Squibb Co.
Daniel S. Berman, MD, FACC
Dr. Berman is Chief of Cardiac Imaging and Nuclear Cardiology at Cedars-Sinai Heart Center and Professor of Medicine at the David Geffen School of Medicine at the University of California, Los Angeles. Board certified in internal medicine and nuclear medicine, Dr. Berman is a world-renowned expert in nuclear cardiology, and is one of the principal developers of techniques that are currently widely used in nuclear cardiology. His recent work involves several clinical trials aimed at improving diagnostics of cardiovascular diseases. Board certified in internal medicine, cardiology and nuclear medicine, Dr. Berman completed residencies in internal medicine and nuclear medicine at UC, Davis and a fellowship in cardiology at UC Davis Medical Center. He received his MD degree from the University of California, San Francisco.
Peter Conti, MD, PhD
Dr. Conti is Professor of Radiology, Biomedical Engineering and Pharmacy at the University of Southern California. He has been the Director of the USC PET Imaging Science Center since its inception in 1991. He served as the President of the Society of Nuclear Medicine and is a major contributor to the development of clinical PET and molecular imaging. One of Dr. Conti’s major research interests is in the development of molecular imaging agents for the diagnosis and monitoring of cancer metabolism and cell proliferation. Dr. Conti is Board certified in both Diagnostic Radiology and Nuclear Medicine. He received both his MD and PhD degrees from Cornell University.
Elazer Edelman, MD, PhD
Dr. Edelman is the Thomas D. and Virginia W. Cabot Professor of Health Sciences and Technology at MIT, Professor of Medicine at Harvard Medical School, and a coronary care unit cardiologist at the Brigham and Women's Hospital in Boston. He and his laboratory have pioneered basic findings in vascular biology and the development and assessment of biotechnology. Dr. Edelman directs the Harvard-MIT Biomedical Engineering Center (BMEC), dedicated to applying the rigors of the physical sciences to elucidate fundamental biologic processes and mechanisms of disease. Dr. Edelman completed internal medicine training and clinical fellowship in Cardiovascular Medicine at the BWH and a research fellowship at the Department of Pathology at Harvard Medical School. Dr. Edelman received his MD degree from Harvard Medical School and a PhD in Medical Engineering and Medical Physics from MIT.
Heinrich Schelbert, MD, PhD
Professor of Pharmacology and Radiological Sciences and a Chief of Cardiovascular Nuclear Medicine at the UCLA School of Medicine. Dr. Schelbert has made several seminal contributions to the field of cardiac PET imaging including development of a radiotracer techniques used in non-invasive blood flow imaging and characterization of the substrate metabolism in the human heart. His on-going research focuses on exploring the regulation of the coronary circulation in the human heart and on the noninvasive characterization of coronary endothelial function as a critical component in the development of atherosclerosis. He is the current Editor–In-Chief of the Journal of Nuclear Medicine. Dr. Schelbert completed residences in Cardiology/Physiology Research at the Heinrich-Heine-Universitat Duesseldorf, Germany and in Internal Medicine at the Mercy Catholic Medical Center. He received both his MD and PhD degrees from the University of Wuerzburg, Germany.
Andrew Selwyn, MA, MD, FRCP (UK), FACC
Dr. Selwyn is a Professor of Medicine at Harvard Medical School and a Senior Physician and Associate Chief of the Cardiovascular Division (academic affairs) at Brigham and Women’s Hospital. He is a leading contributor to the research and clinical practice of interventional cardiology and biology of atherosclerosis. Dr. Selwyn conducted his postdoctoral training at the Royal Postgraduate Medical School in London. He received his MD degree from University of Cape Town, South Africa.